High Risk HRpos HER2neg EBC
InterACT Oncology Team Training: Improving Clinical Outcomes for Patients With High-Risk HR-Positive/HER2-Negative Early-Stage Breast Cancer

Released: July 25, 2024

Expiration: July 24, 2025

Joyce O'Shaughnessy
Joyce O'Shaughnessy, MD
Sara M. Tolaney
Sara M. Tolaney, MD, MPH

Activity

Progress
1
Course Completed